Introduction Non‐pharmacological treatments (NPTs) have the potential to improve meaningful
outcomes for older people at risk of, or living with dementia, but research often lacks …

Background Practice effects (PEs) are improvements in performance after repeated
exposure to test materials, and typically viewed as a source of bias in repeated cognitive …

The global fight against Alzheimer’s disease (AD) poses unique challenges for the field of
neuropsychology. Along with the increased focus on early detection of AD pathophysiology, …

Introduction Detecting functional decline from normal aging to dementia is relevant for
diagnostic and prognostic purposes. Therefore, the Amsterdam IADL Questionnaire (A-IADL-Q) …

Objective To investigate the influence of heterogeneity in disease progression for detecting
treatment effects in Alzheimer disease (AD) trials, using a simulation study. Methods …

Introduction: We investigated whether monthly assessments of a computerized cognitive
composite (C3) could aid in the detection of differences in practice effects (PE) in clinically …

Introduction Primary progressive aphasia (PPA) is divided into three prototypical subtypes
that are all characterized by their single core symptom of aphasia. Although later in their …

A crucial aspect of any clinical trial is using the right outcome measure to assess treatment
efficacy. Compared to the rapidly evolved understanding and measurement of …

Introduction Composite scores may be useful to summarize overall language or visuospatial
functioning in studies of older adults. Methods We used item response theory to derive …

Background As global populations age, cross-national comparisons of cognitive health and
dementia risk are increasingly valuable. It remains unclear, however, whether country-level …